Compliance Continues To Curtail Effective Asthma Treatment
Executive Summary
The top two high-priority challenges to address in asthma treatment for respondents to a large survey by Datamonitor Healthcare of pulmonologists and primary care physicians in the US, Japan and Europe were improving compliance and developing effective, easy-to-use inhalers.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Pharma Firms Welcome 'Pragmatic' EU Reforms But Concerns Persist
The European parliament has voted for legislation it says will lead to fairer, more accessible healthcare. The continent's drugmakers are still not wholly convinced.